Welcome to the New Nuclear Medicine Technologist Section, providing you access to everything you need on the SNMMI website in one place.
The nuclear medicine and molecular imaging technologists are highly specialized healthcare professionals who works closely with the nuclear medicine physician. Some of the technologist’s primary responsibilities are to: Prepare and administer radioactive chemical compounds, known as radiopharmaceuticals and to administer adjunctive medications in order to perform patient imaging procedures using sophisticated instrumentation; Process data and enhance digital images using advanced computer technology; Provide images, data analysis, and patient information to the physician for diagnostic interpretation; and Evaluate new procedures for appropriateness in specific clinical settings and patient populations.
The Society of Nuclear Medicine and Molecular Imaging Technologist Section as part of the SNMMI, is constantly striving to make a difference in the way nuclear medicine and molecular imaging technologists receive academic and continuing education as well as information concerning new procedures, technologies and equipment. Research has been a vital part of SNMMI-TS activities for many years, as has monitoring federal regulation and influencing decisions that affect the practice of nuclear medicine.
In addition to providing discussion forums and publishing journals, newsletters and books, SNMMI-TS also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new scientific advances. The activities of the SNMMI-TS National Council of Representatives, volunteer committee members, and staff focus on improving the quality of care for the patients served by technologists around the world.
SNMMI educational programs are designed to meet the professional development needs of technologists in the field of nuclear medicine and molecular imaging, as well as providing them with continuing education credit opportunities. SNMMI is an ARRT-recognized conitinuing education mechanism (RCEEMs) provider through the Society's Verification Of Involvement in Continuing Education (VOICE) program.
The PET Online Review Workshop is designed to help prepare technologists for the NMTCB's PET Exam. Following the NMTCB's content outline, the workshop offers a comprehensive review of both PET and PET/CT.
The NCT (Nuclear Cardiology Technologist) Online Review Workshop is designed to prepare technologists for the NMTCB's NCT Exam. The course reviews the NMTCB's nuclear cardiology examination content specifications.
Introducing a new member-benefit. Stay on top of the latest trends and advancements in the profession with quarterly technologist-focused webinars—free for SNMMI-TS members.
Make your plans to attend the SNMMI 2015 Annual Meeting, June 6-10 in Baltimore, Maryland.
This year's meeting features more than 150 scientific and CE sessions, including a number of technologist-focused sessions, including:
Network and connect with your peers
Don't miss the opportunity to reconnect with your peers from around the globe during the Annual Meeting's extensive networking and event calendar, including:
Register today and save!
Early-bird Registration deadline: Thursday, April 9, 2015
The spectrum of responsibilities for a nuclear medicine technologist varies widely across the United States. Practice components presented in this document provide a basis for establishing the areas of knowledge and performance for the nuclear medicine technologist. The nuclear medicine technologist must be in compliance with all federal, state, and institutional guidelines, including proper documentation of initial and continued competency in those practices and activities.
Continuing education is a necessary component in maintaining the skills required to perform all duties and tasks of the nuclear medicine technologist in this ever-evolving field.
The Nuclear Medicine Technologist Scope of Practice and Performance Standards document is intended to set forth the standards in important areas of the nuclear medicine technologist’s responsibilities. It may not cover all areas which may present themselves in actual practice. These standards do not supersede the judgment of the individual nuclear medicine technologist and other healthcare professionals serving the patient in light of all of the facts of the individual case. THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGIST SECTION DISCLAIM ALL LIABILITY ARISING FROM USE OF THESE DOCUMENTS.
The SNMMI-TS has a robust grants and awards program sponsored in part by the Education and Research Foundation (ERF). The numerous grants and awards offered spam from financial assistance for tuition for advanced degree programs, travel awards to attend the annual meeting, best abstract awards for abstracts presented during the annual meeting, clinical advancement awards and the leadership academy.
Click here to learn more about all of the available SNMMI-TS awards.
The SNMMI-TS has teamed up with the American Registry for Radiologic Technologists (ARRT) to offer new professional developments grants, with the goal of helping you advance your career as a nuclear medicine technologist. The new AART/SNMMI-TS Professional Development Grants are designed to support up to 13 nuclear medicine technologists wishing to pursue additional educational opportunities, including: SNMMI Annual Meeting attendance, live and online educational courses, ARRT certification exams, and degree seeking education.
Thirteen $500 Grants are available (one per chapter).
Learn more and submit your application.
Application deadline: Monday, April 13, 2015.
Visit SNMMI's Career Center.
Congress adjourned for their spring recess without passing legislation that would permanently repeal Medicare's sustainable growth rate (SGR) and provide incentives for doctors to focus on value-driven care.
(Government Relations News)
On Tuesday March 24, SNMMI submitted comments to the FDA regarding the distinction between nuclear pharmacy and manufacturing.
(Government Relations News)
An international audience came together for the Third Theranostics World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, March 12–14 on the Johns Hopkins Medical Institutes campus in Baltimore, Md. The meeting was co-sponsored by SNMMI and Johns Hopkins.
Researchers from Arizona have developed a florbetapir-PET brain imaging technique to better detect the progression of beta-amyloid plaque deposition, which has been linked with Alzheimer's disease.
(MI: Making a Difference)
April 23, 2015 | 3:00 p.m. ET | Register
Please join Cybil Nielsen, MBA, CNMT, FSMTS, as she discusses the following learning objectives:
1.0 VOICE Credit is available. This webinar is free for SNMMI-TS members and $29 for non-members.